140 related articles for article (PubMed ID: 33816275)
1. NRBP2 Functions as a Tumor Suppressor and Inhibits Epithelial-to-Mesenchymal Transition in Breast Cancer.
Li Z; Liu B; Li C; Sun S; Zhang H; Sun S; Wang Z; Zhang X
Front Oncol; 2021; 11():634026. PubMed ID: 33816275
[TBL] [Abstract][Full Text] [Related]
2. Nuclear Receptor Binding Protein 2 Is Downregulated in Medulloblastoma, and Reduces Tumor Cell Survival upon Overexpression.
Xiong A; Roy A; Spyrou A; Weishaupt H; Marinescu VD; Olofsson T; Hermanson O; Swartling FJ; Forsberg-Nilsson K
Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32517178
[TBL] [Abstract][Full Text] [Related]
3. NRBP2 Overexpression Increases the Chemosensitivity of Hepatocellular Carcinoma Cells via Akt Signaling.
Zhang L; Ge C; Zhao F; Zhang Y; Wang X; Yao M; Li J
Cancer Res; 2016 Dec; 76(23):7059-7071. PubMed ID: 27634758
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of microRNA-190 inhibits migration, invasion, epithelial-mesenchymal transition, and angiogenesis through suppression of protein kinase B-extracellular signal-regulated kinase signaling pathway via binding to stanniocalicin 2 in breast cancer.
Sun G; Liu M; Han H
J Cell Physiol; 2019 Aug; 234(10):17824-17838. PubMed ID: 30993707
[TBL] [Abstract][Full Text] [Related]
5. Anti-Breast Cancer Potential of Quercetin via the Akt/AMPK/Mammalian Target of Rapamycin (mTOR) Signaling Cascade.
Rivera Rivera A; Castillo-Pichardo L; Gerena Y; Dharmawardhane S
PLoS One; 2016; 11(6):e0157251. PubMed ID: 27285995
[TBL] [Abstract][Full Text] [Related]
6. ABCA8 inhibits breast cancer cell proliferation by regulating the AMP activated protein kinase/mammalian target of rapamycin signaling pathway.
Lv C; Yang H; Yu J; Dai X
Environ Toxicol; 2022 Jun; 37(6):1423-1431. PubMed ID: 35191604
[TBL] [Abstract][Full Text] [Related]
7. Fatty acid transport protein-5 (FATP5) deficiency enhances hepatocellular carcinoma progression and metastasis by reprogramming cellular energy metabolism and regulating the AMPK-mTOR signaling pathway.
Wang MD; Wang NY; Zhang HL; Sun LY; Xu QR; Liang L; Li C; Huang DS; Zhu H; Yang T
Oncogenesis; 2021 Nov; 10(11):74. PubMed ID: 34772914
[TBL] [Abstract][Full Text] [Related]
8. SOX18 Affects Cell Viability, Migration, Invasiveness, and Apoptosis in Hepatocellular Carcinoma (HCC) Cells by Participating in Epithelial-to-Mesenchymal Transition (EMT) Progression and Adenosine Monophosphate Activated Protein Kinase (AMPK)/Mammalian Target of Rapamycin (mTOR).
Sun Y; Lei B; Huang Q
Med Sci Monit; 2019 Aug; 25():6244-6254. PubMed ID: 31427562
[TBL] [Abstract][Full Text] [Related]
9. GATA binding protein 1 recruits histone deacetylase 2 to the promoter region of nuclear receptor binding protein 2 to affect the tumor microenvironment and malignancy of thyroid carcinoma.
Li M; Jiang H; Chen S; Ma Y
Bioengineered; 2022 Apr; 13(4):11320-11341. PubMed ID: 35491849
[TBL] [Abstract][Full Text] [Related]
10. Mammalian Target of Rapamycin (mTOR) Regulates Transforming Growth Factor-β1 (TGF-β1)-Induced Epithelial-Mesenchymal Transition via Decreased Pyruvate Kinase M2 (PKM2) Expression in Cervical Cancer Cells.
Cheng KY; Hao M
Med Sci Monit; 2017 Apr; 23():2017-2028. PubMed ID: 28446743
[TBL] [Abstract][Full Text] [Related]
11. The pan-inhibitor of Aurora kinases danusertib induces apoptosis and autophagy and suppresses epithelial-to-mesenchymal transition in human breast cancer cells.
Li JP; Yang YX; Liu QL; Zhou ZW; Pan ST; He ZX; Zhang X; Yang T; Pan SY; Duan W; He SM; Chen XW; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():1027-62. PubMed ID: 25733818
[TBL] [Abstract][Full Text] [Related]
12. Anhydroicaritin Inhibits EMT in Breast Cancer by Enhancing GPX1 Expression: A Research Based on Sequencing Technologies and Bioinformatics Analysis.
Li F; Shi Y; Yang X; Luo Z; Zhang G; Yu K; Li F; Chen L; Zhao Y; Xie Y; Wu Y; Yang J; Zhou X; Liu S
Front Cell Dev Biol; 2021; 9():764481. PubMed ID: 35178395
[No Abstract] [Full Text] [Related]
13. FAM83D promotes epithelial-mesenchymal transition, invasion and cisplatin resistance through regulating the AKT/mTOR pathway in non-small-cell lung cancer.
Yin C; Lin X; Wang Y; Liu X; Xiao Y; Liu J; Snijders AM; Wei G; Mao JH; Zhang P
Cell Oncol (Dordr); 2020 Jun; 43(3):395-407. PubMed ID: 32006253
[TBL] [Abstract][Full Text] [Related]
14. MiR-577 suppresses epithelial-mesenchymal transition and metastasis of breast cancer by targeting Rab25.
Yin C; Mou Q; Pan X; Zhang G; Li H; Sun Y
Thorac Cancer; 2018 Apr; 9(4):472-479. PubMed ID: 29524309
[TBL] [Abstract][Full Text] [Related]
15. Long noncoding RNA H19 acts as a miR-340-3p sponge to promote epithelial-mesenchymal transition by regulating YWHAZ expression in paclitaxel-resistant breast cancer cells.
Yan L; Yang S; Yue CX; Wei XY; Peng W; Dong ZY; Xu HN; Chen SL; Wang WR; Chen CJ; Yang QL
Environ Toxicol; 2020 Sep; 35(9):1015-1028. PubMed ID: 32420678
[TBL] [Abstract][Full Text] [Related]
16. miR-345 inhibits tumor metastasis and EMT by targeting IRF1-mediated mTOR/STAT3/AKT pathway in hepatocellular carcinoma.
Yu M; Xue H; Wang Y; Shen Q; Jiang Q; Zhang X; Li K; Jia M; Jia J; Xu J; Tian Y
Int J Oncol; 2017 Mar; 50(3):975-983. PubMed ID: 28098858
[TBL] [Abstract][Full Text] [Related]
17. Nuclear receptor binding protein 2 is induced during neural progenitor differentiation and affects cell survival.
Larsson J; Forsberg M; Brännvall K; Zhang XQ; Enarsson M; Hedborg F; Forsberg-Nilsson K
Mol Cell Neurosci; 2008 Sep; 39(1):32-9. PubMed ID: 18619852
[TBL] [Abstract][Full Text] [Related]
18. CEP55 promotes epithelial-mesenchymal transition in renal cell carcinoma through PI3K/AKT/mTOR pathway.
Chen H; Zhu D; Zheng Z; Cai Y; Chen Z; Xie W
Clin Transl Oncol; 2019 Jul; 21(7):939-949. PubMed ID: 30607788
[TBL] [Abstract][Full Text] [Related]
19. MiR-135-5p inhibits TGF-β-induced epithelial-mesenchymal transition and metastasis by targeting SMAD3 in breast cancer.
Yang W; Feng W; Wu F; Gao Y; Sun Q; Hu N; Lu W; Zhou J
J Cancer; 2020; 11(21):6402-6412. PubMed ID: 33033523
[TBL] [Abstract][Full Text] [Related]
20. miR-665 expression predicts poor survival and promotes tumor metastasis by targeting NR4A3 in breast cancer.
Zhao XG; Hu JY; Tang J; Yi W; Zhang MY; Deng R; Mai SJ; Weng NQ; Wang RQ; Liu J; Zhang HZ; He JH; Wang HY
Cell Death Dis; 2019 Jun; 10(7):479. PubMed ID: 31209222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
